FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fabrizio De Ponti

Research Profile

Physiology

Anatomy

Living Beings

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Giovanni Dothel; Valentina Vasina; Giovanni Barbara; Fabrizio De Ponti
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues.
Carlo Piccinni; Elisabetta Poluzzi; Chiara Sacripanti; Fabrizio De Ponti
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants.
Carlo Piccinni; Elisabetta Poluzzi; Aurora Puccini; Emanuel Raschi; Björn Wettermark; Giuseppe Boriani; Thomas Cars; Igor Diemberger; Fabrizio De Ponti
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fabrizio De Ponti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Giovanni Dothel; Valentina Vasina; Giovanni Barbara; Fabrizio De Ponti
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues.
Pharmacology & therapeutics 2013;139(1):71-86.
2013: Carlo Piccinni; Elisabetta Poluzzi; Chiara Sacripanti; Fabrizio De Ponti
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants.
Pharmacoepidemiology and drug safety 2013;22(4):443-5.
2013: Carlo Piccinni; Elisabetta Poluzzi; Aurora Puccini; Emanuel Raschi; Björn Wettermark; Giuseppe Boriani; Thomas Cars; Igor Diemberger; Fabrizio De Ponti
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden.
European journal of clinical pharmacology 2013;69(3):715-20.
2013: Fabrizio De Ponti
Drug development for the irritable bowel syndrome: current challenges and future perspectives.
Frontiers in pharmacology 2013;4():7.
2012: Barbara Balestra; Roberto Corinaldesi; Cesare Cremon; Roberto De Giorgio; Fabrizio De Ponti; G Dothel; A Paccapelo; O Pastoris; Vincenzo Stanghellini; Marcello Tonini; Valentina Vasina; Riccardo Vicini; L Zecchi; Giovanni Barbara
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2012;24(12):1118-e570.
2012: Emanuel Raschi; Fabrizio De Ponti
Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology.
Internal and emergency medicine 2012;7(2):113-31.
2011: Emanuel Raschi; Giuseppe Boriani; Ariola Koci; Elisabetta Poluzzi; Fabrizio De Ponti
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus.
British journal of clinical pharmacology 2011;72(5):839-41.
2011: Cesare Cremon; Roberto De Giorgio; Fabrizio De Ponti; David Grundy; Vincenzo Stanghellini; Marcello Tonini; Valentina Vasina; Bingxian Wang; Giovanni Carini; Rosanna F Cogliandro; Roberto Corinaldesi; Giovanni Barbara
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
The American journal of gastroenterology 2011;106(7):1290-8.
2011: Maria Grazia Ursino; Elisabetta Poluzzi; Carla Caramella; Fabrizio De Ponti
Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
Regulatory toxicology and pharmacology : RTP 2011;60(1):93-105.
2011: Elisabetta Poluzzi; Carlo Piccinni; Paolo Carta; Aurora Puccini; Monica Lanzoni; Domenico Motola; Alberto Vaccheri; Fabrizio De Ponti; Nicola Montanaro
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study.
European journal of clinical pharmacology 2011;67(4):407-14.
2011: Emanuel Raschi; Giuseppe Boriani; Fabrizio De Ponti
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling.
Current drug targets 2011;12(2):263-86.
2010: Laurent Ferrier; Claudine Serradeil-Le Gal; Anke M Schulte; Valentina Vasina; Eric Gaultier; Silke Schroedel; Maria Grazia Ursino; Gilles Chaumaz; Marc Pascal; Fabrizio De Ponti; Lionel Bueno
Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD.
American journal of physiology. Gastrointestinal and liver physiology 2010;299(6):G1298-307.
2010: Giuseppe Boriani; Igor Diemberger; Cinzia Valzania; mauro biffi; Cristian Martignani; Emanuel Raschi; Valentina Mantovani; Matteo Ziacchi; Matteo Bertini; Fabrizio De Ponti; Angelo Branzi
Role of drugs and devices in patients at risk of sudden cardiac death.
Fundamental & clinical pharmacology 2010;24(5):575-94.
2010: Valentina Vasina; Massimiliano Broccoli; Maria Grazia Ursino; Donatella Canistro; Luca Valgimigli; Antonio Soleti; Moreno Paolini; Fabrizio De Ponti
Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats.
World journal of gastroenterology : WJG 2010;16(29):3642-50.
2010: Elisabetta Poluzzi; Emanuel Raschi; Domenico Motola; Ugo Moretti; Fabrizio De Ponti
Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.
Drug safety : an international journal of medical toxicology and drug experience 2010;33(4):303-14.
2010: Emanuel Raschi; Valentina Vasina; Maria Grazia Ursino; Giuseppe Boriani; Andrea Martoni; Fabrizio De Ponti
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy.
Pharmacology & therapeutics 2010;125(2):196-218.
2009: Emanuel Raschi; Luisa Ceccarini; Fabrizio De Ponti; Maurizio Recanatini
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation.
Expert opinion on drug metabolism & toxicology 2009;5(9):1005-21.
2009: Valentina Vasina; Massimiliano Broccoli; Maria Grazia Ursino; Simona Fiò Bellot; Antonio Soleti; Moreno Paolini; Fabrizio De Ponti
Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats.
European journal of pharmacology 2009;614(1-3):137-45.
2009: Elisabetta Poluzzi; Emanuel Raschi; Ugo Moretti; Fabrizio De Ponti
Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).
Pharmacoepidemiology and drug safety 2009;18(6):512-8.
2009: Maria Grazia Ursino; Valentina Vasina; Emanuel Raschi; Francesca Crema; Fabrizio De Ponti
The beta3-adrenoceptor as a therapeutic target: current perspectives.
Pharmacological research : the official journal of the Italian Pharmacological Society 2009;59(4):221-34.
2009: Maria Grazia Ursino; Valentina Vasina; Fabrizio De Ponti
Protection from DNBS-induced colitis by the tachykinin NK(1) receptor antagonist SR140333 in rats.
European journal of pharmacology 2009;603(1-3):133-7.
2009: Emanuel Raschi; Elisabetta Poluzzi; Chiara Zuliani; Arno Muller; Herman Goossens; Fabrizio De Ponti
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period.
British journal of clinical pharmacology 2009;67(1):88-98.
2008: Valentina Vasina; E Abu-Gharbieh; Giovanni Barbara; Roberto De Giorgio; R Colucci; C Blandizzi; N Bernardini; Tiziano Croci; M Del Tacca; Fabrizio De Ponti
The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2008;20(9):1030-41.
2008: Emanuel Raschi; Valentina Vasina; Elisabetta Poluzzi; Fabrizio De Ponti
The hERG K+ channel: target and antitarget strategies in drug development.
Pharmacological research : the official journal of the Italian Pharmacological Society 2008;57(3):181-95.
2008: Antonio Drago; Fabrizio De Ponti; Giuseppe Boriani; Diana De Ronchi; Alessandro Serretti
Strategy for a genetic assessment of antipsychotic and antidepressant-related proarrhythmia.
Current medicinal chemistry 2008;15(24):2472-517.
2007: Elisabetta Poluzzi; Petar Strahinja; Alberto Vaccheri; Antonio Vargiu; Maria Chiara Silvani; Domenico Motola; Giulio Marchesini; Fabrizio De Ponti; Nicola Montanaro
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.
British journal of clinical pharmacology 2007;63(3):346-55.
2006: Domenico Motola; Fabrizio De Ponti; Elisabetta Poluzzi; Nello Martini; Pasqualino Rossi; Maria Chiara Silvani; Alberto Vaccheri; Nicola Montanaro
An update on the first decade of the European centralized procedure: how many innovative drugs?
British journal of clinical pharmacology 2006;62(5):610-6.
2006: Domenico Motola; Fabrizio De Ponti
Generic versus brand-name medicinal products: are they really interchangeable?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(8):560-2.
2006: Valentina Vasina; Giovanni Barbara; Luigia Talamonti; Vincenzo Stanghellini; Roberto Corinaldesi; Marcello Tonini; Fabrizio De Ponti; Roberto De Giorgio
Enteric neuroplasticity evoked by inflammation.
Autonomic neuroscience : basic & clinical 2006;126-127():264-72.
2006: Maria Chiara Silvani; Domenico Motola; Elisabetta Poluzzi; Ambrogio Bottoni; Fabrizio De Ponti; Alberto Vaccheri; Nicola Montanaro
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy.
European journal of clinical pharmacology 2006;62(3):235-41.
2005: Marcello Tonini; Riccardo Vicini; Elisabetta Cervio; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Vincenzo Stanghellini; Antonio Dellabianca; Catia Sternini
5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum.
Gastroenterology 2005;129(5):1557-66.
2005: Elisabetta Poluzzi; Petar Strahinja; Antonio Vargiu; Giacomo Chiabrando; Maria Chiara Silvani; Domenico Motola; Giulia Sangiorgi Cellini; Alberto Vaccheri; Fabrizio De Ponti; Nicola Montanaro
Initial treatment of hypertension and adherence to therapy in general practice in Italy.
European journal of clinical pharmacology 2005;61(8):603-9.
2005: Domenico Motola; Fabrizio De Ponti; Pasqualino Rossi; Nello Martini; Nicola Montanaro
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003.
British journal of clinical pharmacology 2005;59(4):475-8.
2005: Elisabetta Moro; Francesca Crema; Cosimo Dandolo; Fabrizio De Ponti; Gianmario Frigo
Effect of muscarinic receptor blockade on canine gastric tone and compliance in vivo.
Pharmacological research : the official journal of the Italian Pharmacological Society 2005;51(4):289-96.
2005: Maurizio Recanatini; Elisabetta Poluzzi; Matteo Masetti; Andrea Cavalli; Fabrizio De Ponti
QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.
Medicinal research reviews 2005;25(2):133-66.
2004: Domenico Motola; Alberto Vaccheri; Maria Chiara Silvani; Elisabetta Poluzzi; Ambrogio Bottoni; Fabrizio De Ponti; Nicola Montanaro
Pattern of NSAID use in the Italian general population: a questionnaire-based survey.
European journal of clinical pharmacology 2004;60(10):731-8.
2004: Eman Abu-Gharbieh; Valentina Vasina; Elisabetta Poluzzi; Fabrizio De Ponti
Antibacterial macrolides: a drug class with a complex pharmacological profile.
Pharmacological research : the official journal of the Italian Pharmacological Society 2004;50(3):211-22.
2004: Roberto De Giorgio; Giovanni Barbara; Vincenzo Stanghellini; Cesare Cremon; Beatrice Salvioli; Fabrizio De Ponti; Roberto Corinaldesi
Diagnosis and therapy of irritable bowel syndrome.
Alimentary pharmacology & therapeutics 2004;20 Suppl 2():10-22.
2004: Roberto De Giorgio; Stefania Guerrini; Giovanni Barbara; Vincenzo Stanghellini; Fabrizio De Ponti; Roberto Corinaldesi; Peter L Moses; Keith Sharkey; Gary M Mawe
Inflammatory neuropathies of the enteric nervous system.
Gastroenterology 2004;126(7):1872-83.
2004: Marcello Tonini; L Cipollina; Elisabetta Poluzzi; Francesca Crema; Gino Roberto Corazza; Fabrizio De Ponti
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.
Alimentary pharmacology & therapeutics 2004;19(4):379-90.
2004: Roberto De Giorgio; Vincenzo Stanghellini; Giovanni Barbara; Stefania Guerrini; Andrea Lioce; Valentina Vasina; Marcello Tonini; Bruno Cola; Roberto Corinaldesi; Fabrizio De Ponti
Prokinetics in the treatment of acute intestinal pseudo-obstruction.
IDrugs : the investigational drugs journal 2004;7(2):160-5.
2004: Elisabetta Moro; Francesca Crema; Fabrizio De Ponti; Gianmario Frigo
Triptans and gastric accommodation: pharmacological and therapeutic aspects.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(1):85-92.
2004: Marcello Tonini; Roberto De Giorgio; Fabrizio De Ponti
Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
Drugs 2004;64(4):347-61.
2004: Elisabetta Poluzzi; Domenico Motola; Chiara Silvani; Fabrizio De Ponti; Alberto Vaccheri; Nicola Montanaro
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement.
European journal of clinical pharmacology 2004;59(11):825-31.
2003: Alessandro Agazzi; Fabrizio De Ponti; Roberto De Giorgio; Stefano M Candura; Laura Anselmi; Elisabetta Cervio; Amalia Di Nucci; Marcello Tonini
Review of the implications of dietary tryptophan intake in patients with irritable bowel syndrome and psychiatric disorders.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(8):590-5.
2003: Roberto De Giorgio; Monica Bovara; Giovanni Barbara; Marco Canossa; Giovanni Sarnelli; Fabrizio De Ponti; Vincenzo Stanghellini; Marcello Tonini; Silvia Cappello; Eleonora Pagnotta; Eduardo Nobile-Orazio; Roberto Corinaldesi
Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility.
Gastroenterology 2003;125(1):70-9.
2003: Fabrizio De Ponti; Francesca Crema; Elisabetta Moro; Giuseppe Nardelli; Gianmario Frigo; Antonio Crema
Role of 5-HT1B/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B/D receptor antagonists.
American journal of physiology. Gastrointestinal and liver physiology 2003;285(1):G96-104.
2003: Mario Alessiani; Fabrizio De Ponti; Filiberto Fayer; Francesca Abbiati; Sandro Zonta; Ermanno Zitelli; Eloisa Arbustini; Patrizia Morbini; Nicoletta Poggi; Catherine Klersy; Ilaria Blangetti; Paolo Dionigi; Aris Zonta
The influence of surgery, immunosuppressive drugs, and rejection, on graft function after small bowel transplantation: a large-animal study.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(5):327-35.
2003: Marcello Tonini; Roberto De Giorgio; V Spelta; G Bassotti; Amalia Di Nucci; Laura Anselmi; Barbara Balestra; Fabrizio De Ponti
5-HT4 receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(4):244-50.
2003: Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
New developments in the treatment of functional dyspepsia.
Drugs 2003;63(9):869-92.
2002: Fabrizio De Ponti; Francesca Crema
Treatment functional GI disease: the complex pharmacology of serotonergic drugs.
British journal of clinical pharmacology 2002;54(6):680-1; author reply 681-2.
2002: Umberto Volta; Roberto De Giorgio; Nunzio Petrolini; V Stangbellini; Giovanni Barbara; Alessandro Granito; Fabrizio De Ponti; Roberto Corinaldesi; Francesco B Bianchi
Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders.
Scandinavian journal of gastroenterology 2002;37(11):1276-81.
2002: Roberto De Giorgio; Giovanni Barbara; Vincenzo Stanghellini; Fabrizio De Ponti; Beatrice Salvioli; Marcello Tonini; Pietro Velio; Gabrio Bassotti; Roberto Corinaldesi
Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases.
The American journal of gastroenterology 2002;97(9):2454-9.
2002: Andrea Cavalli; Elisabetta Poluzzi; Fabrizio De Ponti; Maurizio Recanatini
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
Journal of medicinal chemistry 2002;45(18):3844-53.
2002: Fabrizio De Ponti; Elisabetta Poluzzi; Alberto Vaccheri; Ulf Bergman; Lars Bjerrum; John Ferguson; Kerry J Frenz; Peter McManus; Ingrid Schubert; Gisbert Selke; Georgia Terzis-Vaslamatzis; Nicola Montanaro
Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries.
British journal of clinical pharmacology 2002;54(2):171-7.
2002: Giovanna Cipolla; Francesca Crema; Stefano Sacco; Elisabetta Moro; Fabrizio De Ponti; Gianmario Frigo
Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives.
Pharmacological research : the official journal of the Italian Pharmacological Society 2002;46(1):1-6.
2002: Fabrizio De Ponti
Methylnaltrexone Progenics.
Current opinion in investigational drugs (London, England : 2000) 2002;3(4):614-20.
2002: Francesca Crema; Elisabetta Moro; Giuseppe Nardelli; Fabrizio De Ponti; Gianmario Frigo; Antonio Crema
Role of tachykininergic and cholinergic pathways in modulating canine gastric tone and compliance in vivo.
Pharmacological research : the official journal of the Italian Pharmacological Society 2002;45(4):341-7.
2002: Elisabetta Poluzzi; Davide Resi; P Zuccheri; Domenico Motola; Fabrizio De Ponti; Alberto Vaccheri; Nicola Montanaro
Use of anti-asthmatic drugs in Italy: analysis of prescriptions in general practice in the light of guidelines for asthma treatment.
European journal of clinical pharmacology 2002;58(1):55-9.
2002: Beatrice Salvioli; Monica Bovara; Giovanni Barbara; Fabrizio De Ponti; Vincenzo Stanghellini; Marcello Tonini; Stefania Guerrini; Cesare Cremon; Mauro Degli Esposti; Magdalina Koumandou; Roberto Corinaldesi; Catia Sternini; Roberto De Giorgio
Neurology and neuropathology of the pancreatic innervation.
JOP : Journal of the pancreas 2002;3(2):26-33.
2002: Fabrizio De Ponti; Elisabetta Poluzzi; Andrea Cavalli; Maurizio Recanatini; Nicola Montanaro
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.
Drug safety : an international journal of medical toxicology and drug experience 2002;25(4):263-86.
2001: Fabrizio De Ponti; Francesca Crema; Elisabetta Moro; Giuseppe Nardelli; Tiziano Croci; Gianmario Frigo
Intestinal motor stimulation by the 5-HT4 receptor agonist ML10302: differential involvement of tachykininergic pathways in the canine small bowel and colon.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2001;13(6):543-53.
2001: Roberto De Giorgio; Giovanni Barbara; Vincenzo Stanghellini; Marcello Tonini; Valentina Vasina; Bruno Cola; Roberto Corinaldesi; G Biagi; Fabrizio De Ponti
Review article: the pharmacological treatment of acute colonic pseudo-obstruction.
Alimentary pharmacology & therapeutics 2001;15(11):1717-27.
2001: Fabrizio De Ponti; Elisabetta Poluzzi; Nicola Montanaro
Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus.
European journal of clinical pharmacology 2001;57(3):185-209.
2001: Giovanna Cipolla; S Sacco; Francesca Crema; Elisabetta Moro; Fabrizio De Ponti; Gianmario Frigo
Gastric motor effects of triptans: open questions and future perspectives.
Pharmacological research : the official journal of the Italian Pharmacological Society 2001;43(3):205-10.
2001: Marcello Tonini; V Spelta; Fabrizio De Ponti; Roberto De Giorgio; Gianluigi D'Agostino; Vincenzo Stanghellini; R Corinaldesi; Catia Sternini; Francesca Crema
Tachykinin-dependent and -independent components of peristalsis in the guinea pig isolated distal colon.
Gastroenterology 2001;120(4):938-45.
2001: Fabrizio De Ponti; Marcello Tonini
Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.
Drugs 2001;61(3):317-32.
2000: Mario Alessiani; Fabrizio De Ponti; P Ferrari; Filiberto Fayer; A Viezzoli; Francesca Abbiati; Ermanno Zitelli; A Deho; Eloisa Arbustini; Patrizia Morbini; Nicoletta Poggi; M Scandone; Paolo Dionigi; Aris Zonta
Correlations between functional changes and different grades of acute rejection in swine small bowel allografts.
Transplantation proceedings 2000;32(6):1250-1.
2000: Fabrizio De Ponti; Elisabetta Poluzzi; Nicola Montanaro; J Ferguson
QTc and psychotropic drugs.
Lancet 2000;356(9223):75-6.
2000: Fabrizio De Ponti; Elisabetta Poluzzi; Nicola Montanaro
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.
European journal of clinical pharmacology 2000;56(1):1-18.
2000: Roberto De Giorgio; Vincenzo Stanghellini; Giovanni Barbara; Roberto Corinaldesi; Fabrizio De Ponti; Marcello Tonini; Gabrio Bassotti; Catia Sternini
Primary enteric neuropathies underlying gastrointestinal motor dysfunction.
Scandinavian journal of gastroenterology 2000;35(2):114-22.
2000: Marcello Tonini; Roberto De Giorgio; Fabrizio De Ponti; Catia Sternini; V Spelta; Paolo Dionigi; Giovanni Barbara; Vincenzo Stanghellini; R Corinaldesi
Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations.
British journal of pharmacology 2000;129(1):12-20.
1999: Marcello Tonini; Fabrizio De Ponti; Amalia Di Nucci; Francesca Crema
Review article: cardiac adverse effects of gastrointestinal prokinetics.
Alimentary pharmacology & therapeutics 1999;13(12):1585-91.
1999: Cristina Giaroni; Fabrizio De Ponti; Marco Cosentino; Sergio Lecchini; Gianmario Frigo
Plasticity in the enteric nervous system.
Gastroenterology 1999;117(6):1438-58.
1999: Fabrizio De Ponti; C Modini; G Gibelli; Francesca Crema; Gianmario Frigo
Atypical beta-adrenoceptors mediating relaxation in the human colon: functional evidence for beta3-rather than beta4-adrenoceptors.
Pharmacological research : the official journal of the Italian Pharmacological Society 1999;39(5):345-8.
1999: Francesca Crema; C Modini; Tiziano Croci; Michel Langlois; Fabrizio De Ponti
Intestinal prokinesia by two esters of 4-amino-5-chloro-2- methoxybenzoic acid: involvement of 5-hydroxytryptamine-4 receptors and dissociation from cardiac effects in vivo.
The Journal of pharmacology and experimental therapeutics 1999;288(3):1045-52.
1999: Cristina Giaroni; L Somaini; Franca Marino; Marco Cosentino; A Senaldi; Fabrizio De Ponti; Sergio Lecchini; Gianmario Frigo
Modulation of enteric cholinergic neurons by hetero- and autoreceptors: cooperation among inhibitory inputs.
Life sciences 1999;65(8):813-21.
1998: Fabrizio De Ponti; J R Malagelada
Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management.
Pharmacology & therapeutics 1998;80(1):49-88.
1998: E Caldiroli; Franca Marino; Marco Cosentino; Fabrizio De Ponti; Anna Maria Fietta; Antonino Mazzone; A Zibetti; Sergio Lecchini; Gianmario Frigo
Peripheral benzodiazepine receptor expression on leukocytes and neutrophil function during anticonvulsant monotherapy.
Pharmacology 1998;57(4):215-21.
1997: E Caldiroli; Anna Maria Fietta; Fabrizio De Ponti; Marco Cosentino; Franca Marino; M Taddei; Sergio Lecchini; Gianmario Frigo
Effects of carbamazepine on human PMN function: possible role of peripheral benzodiazepine receptors.
Annals of the New York Academy of Sciences 1997;832():130-4.
1997: Franca Marino; Marco Cosentino; Fabrizio De Ponti; Cristina Giaroni; L Somaini; Raffaella Bombelli; Marco Ferrari; A J Aasen; Sergio Lecchini; Gianmario Frigo
Muscarinic modulation of endogenous noradrenaline release from adrenergic terminals in the guinea-pig colon.
Journal of autonomic pharmacology 1997;17(6):365-72.
1997: Cristina Giaroni; L Somaini; Franca Marino; Marco Cosentino; Olivia Leoni; Fabrizio De Ponti; Sergio Lecchini; Gianmario Frigo
Acetylcholine detection by a modified HPLC-ED method improves the assessment of cholinergic function in the myenteric plexus of the guinea-pig colon.
Neuroscience letters 1997;232(1):9-12.
1997: E Caldiroli; Fabrizio De Ponti; Marco Cosentino; Franca Marino; Anna Maria Fietta; M Taddei; Amelia Tartara; A Zibetti; Antonino Mazzone; Sergio Lecchini; Gianmario Frigo
Carbamazepine affects neutrophil function through an action on peripheral benzodiazepine receptors.
Immunopharmacology and immunotoxicology 1997;19(3):367-82.
1997: A Costa; Fabrizio De Ponti; Marco Spada; Eloisa Arbustini; Patrizia Morbini; S Vaccarisi; Filiberto Fayer; M Dermitzakis; M Douvli; Francesca Crema; Mario Alessiani; Antonio Crema
Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score.
Transplantation proceedings 1997;29(3):1809-10.
1997: Mario Alessiani; Marco Spada; A Costa; Eloisa Arbustini; Patrizia Morbini; Nicoletta Poggi; L Favaro; Fabrizio De Ponti; S Noli; Paolo Dionigi; Aris Zonta
Morphological and functional changes in small-bowel allografts of pigs under combined tacrolimus and mycophenolate mofetil immunosuppression.
Transplantation proceedings 1997;29(1-2):691-2.
1997: A Costa; Fabrizio De Ponti; G Gibelli; Francesca Crema; L d'Angelo
In vivo characterization of the colonic prokinetic effect of erythromycin in the rabbit.
Pharmacology 1997;54(2):64-75.
1997: Donatella Gritti; C Canale; Gianluca Fossati; Iolanda Mazzucchelli; Sergio Lecchini; Fabrizio De Ponti; Gianmario Frigo; Antonino Mazzone
Flow cytometry assay of peripheral benzodiazepine receptors (pBZrs) on leukocytes following carbamazepine treatment.
European journal of histochemistry : EJH 1997;41 Suppl 2():111-2.
1996: A Costa; Mario Alessiani; Fabrizio De Ponti; Marco Spada; M Merli; S Zanola; D Barbera; J Rademacher; E Drivas; A Crema
Stimulatory effect of FK506 and erythromycin on pig intestinal motility.
Transplantation proceedings 1996;28(5):2571-2.
1996: A Costa; Fabrizio De Ponti; Marco Spada; Mario Alessiani; D Barbera; P Ferrari; S Zanola; Patrizia Morbini; Eloisa Arbustini; A Crema
Reduced intestinal myoelectrical activity during rejection of small bowel allografts in pigs.
Transplantation proceedings 1996;28(5):2554-5.
1996: Fabrizio De Ponti; G Gibelli; Tiziano Croci; M Arcidiaco; Francesca Crema; Luciano Manara
Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A.
British journal of pharmacology 1996;117(7):1374-6.
1996: Fabrizio De Ponti; Cristina Giaroni; Marco Cosentino; Sergio Lecchini; Gianmario Frigo
Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications.
Pharmacology & therapeutics 1996;69(1):59-78.
1995: Fabrizio De Ponti; G Gibelli; Francesca Crema; Sergio Lecchini
Functional evidence for the presence of beta 3-adrenoceptors in the guinea pig common bile duct and colon.
Pharmacology 1995;51(5):288-97.
1995: Marco Cosentino; Franca Marino; Fabrizio De Ponti; Cristina Giaroni; L Somaini; Olivia Leoni; Sergio Lecchini; Gianmario Frigo
Tonic modulation of neurotransmitter release in the guinea-pig myenteric plexus: effect of mu and kappa opioid receptor blockade and of chronic sympathetic denervation.
Neuroscience letters 1995;194(3):185-8.
1995: Fabrizio De Ponti; Marco Cosentino; A Costa; M Girani; G Gibelli; L D'Angelo; Gianmario Frigo; A Crema
Inhibitory effects of SR 58611A on canine colonic motility: evidence for a role of beta 3-adrenoceptors.
British journal of pharmacology 1995;114(7):1447-53.
1995: Marco Cosentino; Fabrizio De Ponti; Franca Marino; Cristina Giaroni; Olivia Leoni; Sergio Lecchini; Gianmario Frigo
N-methyl-D-aspartate receptors modulate neurotransmitter release and peristalsis in the guinea pig isolated colon.
Neuroscience letters 1995;183(1-2):139-42.
1994: L D'Angelo; Fabrizio De Ponti; Francesca Crema; M Caravaggi; A Crema
Effect of food on the bioavailability of pidotimod in healthy volunteers.
Arzneimittel-Forschung 1994;44(12A):1473-5.
1994: Franca Marino; M Marcoli; Fabrizio De Ponti; Marco Cosentino; Sergio Lecchini; Gianmario Frigo
Effect of desipramine-induced blockade of neuronal uptake mechanisms on adrenoceptor-mediated responses in the guinea-pig colon.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(5):499-506.
1994: Mario Alessiani; Marco Spada; S Vischi; Marcello Maestri; Paolo Dionigi; Eloisa Arbustini; Paolo Grossi; Giovanbattista Ippoliti; Mario Regazzi; Fabrizio De Ponti
Total orthotopic small bowel transplantation in swine under FK 506.
Transplantation proceedings 1994;26(3):1606-8.
1994: Marco Spada; Fabrizio De Ponti; Mario Alessiani; A Costa; M Girani; Paolo Dionigi; S Vischi; G Peloni; J Reyes; Satoru Todo
Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs.
Transplantation proceedings 1994;26(3):1537-9.
1994: Fabrizio De Ponti; Marco Cosentino; L D'Angelo; Gianmario Frigo; A Crema
Prolonged monitoring of colonic spike activity by a computerized system: application to the rabbit colon.
The Italian journal of gastroenterology 1994;26(1):1-6.
1993: Fabrizio De Ponti; Cristina Giaroni; Marco Cosentino; Sergio Lecchini; Gianmario Frigo
Calcium-channel blockers and gastrointestinal motility: basic and clinical aspects.
Pharmacology & therapeutics 1993;60(1):121-48.
1993: Franca Marino; F Creta; Fabrizio De Ponti; Cristina Giaroni; Sergio Lecchini; Gianmario Frigo
Opioid pathways exert a tonic restraint in the guinea-pig isolated colon: changes after chronic sympathetic denervation.
The Journal of pharmacy and pharmacology 1993;45(7):668-70.
1993: Franca Marino; M Marcoli; Fabrizio De Ponti; Sergio Lecchini; C M Castelletti; Gianmario Frigo
Inhibition of endogenous acetylcholine release by blockade of voltage-dependent calcium channels in enteric neurons of the guinea-pig colon.
The Journal of pharmacy and pharmacology 1993;45(5):449-52.
1993: Fabrizio De Ponti; Sergio Lecchini; Marco Cosentino; C M Castelletti; Alberto Malesci; G M Frigo
Immunological adverse effects of anticonvulsants. What is their clinical relevance?
Drug safety : an international journal of medical toxicology and drug experience 1993;8(3):235-50.
1993: Fabrizio De Ponti; A Einaudi; Marco Cosentino; L D'Angelo; S Lecchini; Gianmario Frigo; A Crema
Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
The Journal of pharmacology and experimental therapeutics 1993;264(2):789-94.
1992: Marco Cosentino; Fabrizio De Ponti; L D'Angelo; A Crema
Motility of rabbit proximal colon. Relevance of cholinergic pathways and role of different muscarinic receptor subtypes.
Digestive diseases and sciences 1992;37(11):1746-53.
1992: Fabrizio De Ponti; A Einaudi; Marco Cosentino; L D'Angelo; Gianmario Frigo; A Crema
Effect of calcium channel blockers on postprandial gastrointestinal motility in the dog.
The Journal of pharmacy and pharmacology 1992;44(3):227-30.
1992: Fabrizio De Ponti; Marco Cosentino; L D'Angelo; Sergio Lecchini; Gianmario Frigo; A Crema
Control of intestinal motility by different receptor systems.
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;25 Suppl 1():119-20.
1992: Giovanni Ricevuti; Antonino Mazzone; D Pasotti; M Marcoli; Fabrizio De Ponti; Sergio Lecchini; Gianmario Frigo
Interaction between (-)naloxone and morphine in modifying superoxide generation from human granulocytes.
Immunopharmacology and immunotoxicology 1992;14(3):515-21.
1991: Fabrizio De Ponti; Marco Cosentino; Sergio Lecchini; Gianmario Frigo; A Crema
Physiopharmacology of the peristaltic reflex: an update.
The Italian journal of gastroenterology 1991;23(5):264-9.
1991: Sergio Lecchini; M Marcoli; Fabrizio De Ponti; C A Castelletti; Gianmario Frigo
Selectivity of Ca2+ channel blockers in inhibiting muscular and nerve activities in isolated colon.
British journal of pharmacology 1991;102(3):735-41.
1991: Fabrizio De Ponti; L D'Angelo; Roy FORSTER; A Einaudi; A Crema
Effect of iron succinyl-protein complexes on gastrointestinal motility in the fasting dog.
Digestion 1991;50(2):72-81.
1991: Fabrizio De Ponti; C Marelli; L D'Angelo; M Caravaggi; L Bianco; Sergio Lecchini; Gianmario Frigo; A Crema
Pharmacological activity and safety of trandolapril (RU 44570) in healthy volunteers.
European journal of clinical pharmacology 1991;40(2):149-53.
1990: Fabrizio De Ponti; Marco Cosentino; L D'Angelo; Sergio Lecchini; Gianmario Frigo; A Crema
Importance of cholinergic pathways in the regulation of colonic motility in the rabbit.
Pharmacological research : the official journal of the Italian Pharmacological Society 1990;22 Suppl 3():25-6.
1990: R Grimaldi; Fabrizio De Ponti; L D'Angelo; M Caravaggi; G Guidi; Sergio Lecchini; Gianmario Frigo; A Crema
Pharmacokinetics of the total triterpenic fraction of Centella asiatica after single and multiple administrations to healthy volunteers. A new assay for asiatic acid.
Journal of ethnopharmacology 1990;28(2):235-41.
1989: M Marcoli; Fabrizio De Ponti; Sergio Lecchini; A Crema; Gianmario Frigo
[3H]acetylcholine release from the guinea-pig distal colon: comparison with ileal [3H]acetylcholine release and effect of adrenoceptor stimulation.
The Journal of pharmacy and pharmacology 1989;41(12):824-8.
1989: Fabrizio De Ponti; L Ambrosoli; L D'Angelo; Sergio Lecchini; Gianmario Frigo; A Crema
Regulation of intestinal motility by different muscarinic receptor subtypes.
Pharmacological research : the official journal of the Italian Pharmacological Society 1989;21 Suppl 1():89-90.
1989: Fabrizio De Ponti; M Marcoli; Sergio Lecchini; Luigi Manzo; Gianmario Frigo; A Crema
Effect of beta-casomorphins on intestinal propulsion in the guinea-pig colon.
The Journal of pharmacy and pharmacology 1989;41(5):302-5.
1989: Fabrizio De Ponti; L Ambrosoli; M Borsa; L D'Angelo; Gianmario Frigo; A Crema
Inhibitory effects of DF 594, a new antispasmodic agent, on intestinal motility in the dog.
Pharmacology 1989;38(6):374-80.
1989: A Crema; Fabrizio De Ponti
Recent advances in the physiology and pharmacology of intestinal motility.
Pharmacological research : the official journal of the Italian Pharmacological Society 1989;21(1):67-73.
1985: M Marcoli; Sergio Lecchini; Fabrizio De Ponti; L D'Angelo; A Crema; Gianmario Frigo
Subsensitivity of enteric cholinergic neurones to alpha 2-adrenoceptor agonists after chronic sympathetic denervation.
Naunyn-Schmiedeberg's archives of pharmacology 1985;329(3):271-7.
1985: M Marcoli; G Gatti; G Ippoliti; M Lombardi; A Crema; M T Zocchi; Fabrizio De Ponti; Sergio Lecchini; Gianmario Frigo
Effect of chronic anticonvulsant monotherapy on lymphocyte subpopulations in adult epileptic patients.
Human toxicology 1985;4(2):147-57.